IMMvention Therapeutix, Inc.

Immune Interventions for Human Diseases

IMMvention Therapeutix, co-founded at UNC-Chapel Hill by Dr. Jenny Ting, is focused on improving the lives of patients with rare and prevalent inflammatory diseases of huge unmet needs (such as Rheumatoid Arthritis, Osteoarthritis, Alzheimer’s etc.). The company is discovering and developing first-in-class novel disease modifying therapies that inhibit the inflammation caused by activation of multiple inflammasomes. The company’s first venture capital financing was in December 2020 from leading institutional firms, including Osage University Partners and Hatteras Venture Partners. Prior to its venture financing, IMMvention was funded by North Carolina Biotechnology Center, NIH SBIR grants/contracts and Pharma collaborations.

Presenter: Anil Goyal, CEO, IMMvention Therapeutix

How to connect:

Email: anil@immventionthera.com
Web: immventionthera.com
LinkedIn: linkedin.com/company/immvention-therapeutix-inc